TXNIP and diabetes mellitus: In patients with diabetes, there is an increased expression of renal NOX5 associated with enhanced ROS formation and the upregulation of ROS-sensitive pathways as early growth response 1 (EGR-1), protein kinase C-α (PKC-α), and thioredoxin-interacting protein (TXNIP).